SGCM
HALO icon

Sanchez Gaunt Capital Management’s Halozyme HALO Stock Holding History

Sanchez Gaunt Capital Management’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$237K Sell
3,033
-265
-8% -$18.1K 0.13% 169
2026
Q1 		$213K Buy
+3,298
New +$232K 0.13% 174

Other funds holding HALO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Sanchez Gaunt Capital Management's HALO Position: Q2 2026 in Review

Sanchez Gaunt Capital Management reduced its Halozyme (HALO) stake by 8% in Q2 2026, selling an estimated $18.1K and leaving 3,033 shares worth $237K. The position accounts for 0.13% of the portfolio, ranked #169.

Sanchez Gaunt Capital Management first reported a position in HALO in Q1 2026 and has held it in 2 quarters since. 665 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Sanchez Gaunt Capital Management held 3,033 shares of Halozyme worth $237K as of Q2 2026.
  • Sanchez Gaunt Capital Management sold 265 Halozyme shares in Q2 2026, an estimated $18.1K.
  • Halozyme made up 0.13% of Sanchez Gaunt Capital Management's portfolio in Q2 2026, its #169 holding.
  • Sanchez Gaunt Capital Management first reported a position in Halozyme in Q1 2026 and has held it in 2 quarters since.
  • 665 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Sanchez Gaunt Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.